These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28162003)

  • 1. Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis.
    Kee KM; Lu SN
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):277-279. PubMed ID: 28162003
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast-enhanced ultrasonography: a recent application for the diagnosis and treatment of hepatocellular carcinoma.
    Maruyama K; Yoshikawa M; Yokosuka O
    JNMA J Nepal Med Assoc; 2008; 47(171):156-66. PubMed ID: 19079385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma.
    Kudo M; Hatanaka K; Kumada T; Toyoda H; Tada T
    Am J Gastroenterol; 2011 Feb; 106(2):368-70. PubMed ID: 21301463
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma and liver metastases.
    Seitz K
    Ultraschall Med; 2005 Aug; 26(4):267-9. PubMed ID: 16123919
    [No Abstract]   [Full Text] [Related]  

  • 5. Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective study.
    Boozari B; Soudah B; Rifai K; Schneidewind S; Vogel A; Hecker H; Hahn A; Schlue J; Dietrich CF; Bahr MJ; Kubicka S; Manns MP; Gebel M
    Dig Liver Dis; 2011 Jun; 43(6):484-90. PubMed ID: 21377941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: evaluation with contrast-enhanced power Doppler sonography and contrast-enhanced harmonic imaging.
    Esteban JM; Gil J
    Acad Radiol; 2002 Aug; 9 Suppl 2():S382-3. PubMed ID: 12188283
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline.
    Guo LH; Xu HX
    Biomed Res Int; 2015; 2015():349172. PubMed ID: 26090401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best cases from the AFIP: fibrolamellar hepatocellular carcinoma.
    Smith MT; Blatt ER; Jedlicka P; Strain JD; Fenton LZ
    Radiographics; 2008; 28(2):609-13. PubMed ID: 18349461
    [No Abstract]   [Full Text] [Related]  

  • 10. QUIZ HQ 54. Contrast-enhanced ultrasound (CEUS) for the detection and assessment of treatment efficacy in focal liver lesions.
    Gheorghe L; Carabelea A; Vadan R; Becheanu G
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):473-4. PubMed ID: 20076821
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatocellular carcinoma: Advances in diagnostic imaging.
    Sun H; Song T
    Drug Discov Ther; 2015 Oct; 9(5):310-8. PubMed ID: 26632539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focus on treatment of large hepatocellular carcinoma.
    Abdalla EK; Vauthey JN
    Ann Surg Oncol; 2004 Dec; 11(12):1035-6. PubMed ID: 15576831
    [No Abstract]   [Full Text] [Related]  

  • 13. Some unusual complications of malignancies: case 1. Spontaneous rupture of hepatocellular carcinoma demonstrated by contrast-enhanced sonography.
    Chou YH; Chiou HJ; Tiu CM; Chen JD; Hung GS; Chiang JH
    J Clin Oncol; 2002 Oct; 20(19):4108-11. PubMed ID: 12351607
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatocellular carcinoma: harmonic ultrasound and contrast agent.
    Kim TK; Kim AY; Choi BI
    Abdom Imaging; 2002; 27(2):129-38. PubMed ID: 11847572
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultrasound Evaluation in Patients at Risk for Hepatocellular Carcinoma.
    Fetzer DT; Rodgers SK; Seow JH; Dawkins AA; Joshi G; Gabriel H; Kamaya A
    Radiol Clin North Am; 2019 May; 57(3):563-583. PubMed ID: 30928078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous alcohol instillation therapy (PAI) and chemoembolization in extensive hepatocellular carcinoma].
    Adamus R; Tesdal IK; Georgi M
    Rofo; 1997 Feb; 166(2):173-5. PubMed ID: 9116264
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic effect of TAE in patients with hepatocellular carcinoma using color Doppler imaging with intravenous ultrasound contrast agent].
    Kimura M; Sato M; Shioyama Y; Hagihira T; Horihata K; Terada M; Kishi K; Tanaka K; Kawai N
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 May; 60(6):320-3. PubMed ID: 10860382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations.
    Mitchell DG; Bashir MR; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):143-148. PubMed ID: 28779335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis.
    Dănilă M; Sporea I; Sirli R; Popescu A; Sendroiu M; Martie A
    Med Ultrason; 2010 Jun; 12(2):145-9. PubMed ID: 21173943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.